Combination of Phenethyl Isothiocyanate and Dasatinib Inhibits Hepatocellular Carcinoma Metastatic Potential through FAK/STAT3/Cadherin Signalling and Reduction of VEGF Secretion.

Strusi, Gabriele; Suelzu, Caterina M; Weldon, Shannon; Giffin, Jennifer; Münsterberg, Andrea E; Bao, Yongping

Strusi, Gabriele; Suelzu, Caterina M; Weldon, Shannon; Giffin, Jennifer; Münsterberg, Andrea E; Bao, Yongping.

Afiliação

Strusi G; Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
Suelzu CM; Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
Weldon S; School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Giffin J; School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Münsterberg AE; School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Bao Y; Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.

Pharmaceutics ; 15(10)2023 Sep 27.

Article em En | MEDLINE | ID: mdl-37896150

Palavras-chave

CAM assay; FAK; HCC; PEITC; VEGF; cancer therapeutics; combination therapy; dasatinib; drug development; oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido